Holen Sie sich die Stockscreener-App
2.1576
0.36%
-0.0176
Schlusskurs vom Vortag:
$2.14
Offen:
$2.18
24-Stunden-Volumen:
21,867
Relative Volume:
0.03
Marktkapitalisierung:
$6.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.27M
KGV:
-0.1008
EPS:
-21.4132
Netto-Cashflow:
$-9.40M
1W Leistung:
-2.18%
1M Leistung:
-26.47%
6M Leistung:
-67.18%
1J Leistung:
-83.08%
1-Tages-Spanne:
$2.1002
$2.18
1-Wochen-Bereich:
$2.10
$2.43
52-Wochen-Spanne:
$1.58
$23.70
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Firmenname
Dermata Therapeutics Inc
Sektor
Branche
Telefon
(858)-223-0882
Adresse
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Vergleichen Sie DRMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
2.1545 | 6.84M | 0 | -11.27M | -9.40M | -21.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
471.19 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
810.84 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.64 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
815.91 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.19 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten
Axillary Hyperhidrosis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Botanix Pharma, Sound Surgical Tech, Dr. August Wolff GmbH, Medy-Tox, Journey Medical Corp. - Barchart.com
What dividend safety score for Dermata Therapeutics Inc. Equity Warrant stockJuly 2025 Big Picture & Daily Profit Focused Screening - ulpravda.ru
Is Dermata Therapeutics Inc. stock a top pick in earnings seasonMarket Movers & Free Expert Verified Stock Movement Alerts - ulpravda.ru
Why Dermata Therapeutics Inc. Equity Warrant stock is popular among millennialsTrade Exit Summary & Smart Investment Allocation Insights - ulpravda.ru
Is Dermata Therapeutics Inc. stock a contrarian buyJuly 2025 Catalysts & Safe Entry Zone Tips - ulpravda.ru
Is Dermata Therapeutics Inc. stock trading at a premium valuationJuly 2025 Setups & Safe Entry Trade Signal Reports - ulpravda.ru
Aug Ideas: How Dermata Therapeutics Inc. Equity Warrant stock reacts to oil pricesGap Up & Scalable Portfolio Growth Methods - ulpravda.ru
Will Dermata Therapeutics Inc. stock outperform growth indexesWeekly Trade Summary & Real-Time Volume Trigger Notifications - ulpravda.ru
Why Dermata Therapeutics Inc. Equity Warrant stock is a value investor pick2025 Market Trends & Community Consensus Trade Signals - ulpravda.ru
How Dermata Therapeutics Inc. stock benefits from global expansion2025 Biggest Moves & Technical Entry and Exit Tips - ulpravda.ru
Dermata Therapeutics Inc Equity Warrant Stock Analysis and ForecastBullish Engulfing Patterns & Free Phenomenal Capital Appreciation - earlytimes.in
Pre-market Movers: RSLS, STSS, VERO, KTTA... - RTTNews
Dermata Therapeutics Inc. (DRMA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Dermata Therapeutics announces $2.55M private offering - MSN
Top 5 stocks to watch today | December 30th - MSN
Dermata Therapeutics: Is Change on the Horizon? - StocksToTrade
Dermata Therapeutics: Unveiling Bold Moves - timothysykes.com
Top 5 Stocks To Watch Today | December 30th - MSN
Stock Market Today: S&P 500, Dow Jones Futures Trade Mixed Amid Blip In Santa Claus Rally—Boeing, Freeport-McMoRan, Fonar In Focus - Benzinga
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
Dermata stock surges after closing $4.1 million private placement By Investing.com - Investing.com Australia
Dermata stock surges after closing $4.1 million private placement - Investing.com
Dermata Therapeutics Signs Multiple Material Agreements - TradingView — Track All Markets
Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Weatherford Democrat
Skincare firm Dermata raises $4.1M to back new over-the-counter acne kit - Stock Titan
Bank Watch: Why Dermata Therapeutics Inc Equity Warrant stock is popular among millennialsQuarterly Profit Report & High Accuracy Investment Entry Signals - moha.gov.vn
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Fox21Online
Dermata Therapeutics, Inc.Warrant (NQ: DRMAW - FinancialContent
Dermata Therapeutics’ Skincare Innovation Sparks Interest - StocksToTrade
Dermata Therapeutics, Inc. (DRMA) Stock: Surges 25% as Insider-Backed $4.1M Offering Fuels Momentum - parameter.io
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Why Is Dermata Therapeutics Stock Surging Wednesday? - Sahm
Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today? - Menafn.com
Dermata Therapeutics stock soars after securing $4.1 million private placement By Investing.com - Investing.com Nigeria
Dermata Therapeutics stock soars after securing $4.1 million private placement - Investing.com Nigeria
DRMA Stocks Thrive: Time for Action? - timothysykes.com
Why did Dermata Therapeutics stock surge 22% pre-market today? - MSN
Dermata lines up as much as $12.4M to help launch OTC acne kit - Stock Titan
Ingersoll (500210) Stock RalliesVolume Profile Analysis & Investment Recommendations You Can Trust - Bollywood Helpline
Dermata Therapeutics, Inc. announced that it expects to receive $4.124468 million in funding - marketscreener.com
Can Dermata Therapeutics Inc. Equity Warrant stock deliver consistent earnings growthTrade Volume Report & Smart Money Movement Alerts - Улправда
Quarterly Risk: How interest rate cuts could boost ESGRO stockJuly 2025 Market Mood & Free Verified High Yield Trade Plans - Улправда
Will Dermata Therapeutics Inc. stock reach all time highs in 20252025 Trading Volume Trends & Stock Portfolio Risk Management - Улправда
How buybacks impact Dermata Therapeutics Inc. stock valueLayoff News & Community Supported Trade Ideas - Улправда
Why Dermata Therapeutics Inc. Equity Warrant stock could rally in 2025Quarterly Portfolio Report & Accurate Entry/Exit Alerts - Улправда
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):